Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inmunomodulador")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 18271

  • Page / 731

Export

Selection :

  • and

Immunomodulators as an antimicrobial toolPIROFSKI, Liise-Anne; CASADEVALL, Arturo.Current opinion in microbiology. 2006, Vol 9, Num 5, pp 489-495, issn 1369-5274, 7 p.Article

IMiDs : A novel class of immunomodulatorsKNIGHT, Robert.Seminars in oncology. 2005, Vol 32, Num 4, pp S24-S30, issn 0093-7754, SUP5Article

Immunomodulateurs et grossesseFALGARONE, G; SAIDENBERG-KERMANAC'H, N; BOISSIER, M.-C et al.L' Actualité rhumatologique. 2004, pp 411-421, issn 0065-1818, 11 p.Article

Thalidomide: 40 years onDIGGLE, G. E.International journal of clinical practice (Esher). 2001, Vol 55, Num 9, pp 627-631, issn 1368-5031Article

Psoriasiform Drug Eruption due to AbataceptKATO, Kohei; SATOH, Takahiro; NISHIZAWA, Aya et al.Acta dermato-venereologica. 2011, Vol 91, Num 3, pp 362-363, issn 0001-5555, 2 p.Article

Pharmacologie générale d'un nouvel antirhumatismal, le lobenzaritKAKIMOTO, M; WATANABE, M; HATA, S et al.Yakuri to chiryo. 1987, Vol 15, Num 12, pp 227-253, issn 0386-3603Article

Mushroom immunomodulators: unique molecules with unlimited applicationsEL ENSHASY, Hesham A; HATTI-KAUL, Rajni.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 12, pp 668-677, issn 0167-7799, 10 p.Article

Éruption paradoxale psoriasiforme induite par l'abatacept (ORENCIA®) = Paradoxical psoriasiform eruption due to abatacept (ORENCIA®)SCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 12, pp 871-872, issn 0151-9638, 2 p.Article

Italian Association of Immunopharmacology. CongressPharmacological research. 1992, Vol 26, issn 1043-6618, 207 p., SUP2Conference Proceedings

Rilonacept and canakinumabDUBOIS, Eline A; RISSMANN, Robert; COHEN, Adam F et al.British journal of clinical pharmacology. 2011, Vol 71, Num 5, pp 639-641, issn 0306-5251, 3 p.Article

Mycophenolate Mofetil in Minimal Change NephrosisALFRED, R; SOYIBO, A. K.West indian medical journal. 2010, Vol 59, Num 3, pp 330-331, issn 0043-3144, 2 p.Article

Comparison of the Immunoregulatory Function of Different Constituents in Radix Astragali and Radix HedysariJING LIU; XUGUANG HU; QUAN YANG et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 479426.1-479426.12, 1Article

A patient's wish: anakinra in pregnancyBERGER, C. T; RECHER, M; STEINER, U et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 11, pp 1794-1795, issn 0003-4967, 2 p.Article

Mycophenolate mofetil in dermatologyORVIS, Alissa K; WESSON, Stanton K; BREZA, Thomas S et al.Journal of the American Academy of Dermatology. 2009, Vol 60, Num 2, pp 183-199, issn 0190-9622, 17 p.Article

The immunomodulatory role of human conjunctival epithelial cellsHONG ZHAN; TOWLER, Hamish M. A. T; CALDER, Virginia L et al.Investigative ophthalmology & visual science. 2003, Vol 44, Num 9, pp 3906-3910, issn 0146-0404, 5 p.Article

Immune modulators as antiviral agentsSTEELE, R. W; CHARLTON, R. K.Clinics in laboratory medicine. 1987, Vol 7, Num 4, pp 911-924, issn 0272-2712Article

The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytesFIORENTINO, D. F; CHEN, R. O; STEWART, D. B et al.British journal of dermatology (1951). 2011, Vol 164, Num 5, pp 996-1003, issn 0007-0963, 8 p.Article

Étanercept = EtanerceptDESCAMPS, V.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 845-847, issn 0151-9638, 3 p.Article

EculizumabDUBOIS, ElineA; COHEN, Adam F.British journal of clinical pharmacology. 2009, Vol 68, Num 3, pp 318-319, issn 0306-5251, 2 p.Article

Immunomodulateurs en rhumatologie et risques infectieux : Rhumatologie = Infectious risks of immunomodulating the rapies in rhumatologyVAN DELDEN, C.Revue médicale suisse. 2006, Vol 2, Num 57, issn 1660-9379, 738-745 [6 p.]Article

Influence of peroral application of a herbal immunomodulator on the antibody production of Peyer's patches cellsBODINET, Cornelia; LINDEQUIST, Ulrike; TEUSCHER, Eberhard et al.Arzneimittel-Forschung. 2004, Vol 54, Num 2, pp 114-118, issn 0004-4172, 5 p.Article

Synthesis and immunoadjuvant activity of 1-S and/or 6-O-(ω-amino) fatty acylated derivatives of N-acetyl-1-thio-muramoyl-L-alanyl-D-isoglutamine methyl esterISHIDA, H; KIGAWA, K; KITAGAWA, M et al.Agricultural and biological chemistry. 1991, Vol 55, Num 5, pp 1437-1440, issn 0002-1369Article

Immunological effect of two synthetic peptides containing alanine or D-alanine instead of acetyl group of thymosin β4 after treatment of human serumABIKO, T; SEKINO, H.Chemical and pharmaceutical bulletin. 1990, Vol 38, Num 9, pp 2602-2605, issn 0009-2363, 4 p.Article

Immunomodulatory activities of glucocorticoids: Insights from transgenesis and gene targeting : Transcription factors as targets of novel therapeutic approaches of autoimmune diseasesREICHARDT, H. M.Current pharmaceutical design. 2004, Vol 10, Num 23, pp 2797-2805, issn 1381-6128, 9 p.Article

Clinical implications of the immunomodulatory effects of macrolidesTAMAOKI, Jun; KADOTA, Junichi; TAKIZAWA, Hajime et al.The American journal of medicine. 2004, Vol 117, Num 9A, pp 5S-11S, issn 0002-9343Conference Paper

  • Page / 731